LungLife AI Inc (LSE:LLAI) — Market Cap & Net Worth
Market Cap & Net Worth: LungLife AI Inc (LLAI)
LungLife AI Inc (LSE:LLAI) has a market capitalization of $15.48K (GBX127.23 Million) as of September 23, 2026. Listed on the LSE stock exchange, this UK-based company holds position #31780 globally and #1282 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LungLife AI Inc's stock price GBX4.15 by its total outstanding shares 30658600 (30.66 Million). Also see LLAI total assets for a full breakdown of the balance sheet.
LungLife AI Inc Market Cap History: 2021 to 2025
LungLife AI Inc's market capitalization history from 2021 to 2025. Data shows change from $701.29K to $15.48K (-63.30% CAGR). Also see LLAI cash flow conversion for how efficiently the company converts equity into cash flow.
LungLife AI Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LungLife AI Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check LungLife AI Inc (LLAI) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
3.73x
LungLife AI Inc's market cap is 3.73 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $701.29K | $195.57K | -$7.44 Million | 3.59x | N/A |
| 2022 | $317.07K | $24.00K | -$7.61 Million | 13.21x | N/A |
| 2023 | $171.59K | $46.00K | -$5.41 Million | 3.73x | N/A |
Competitor Companies of LLAI by Market Capitalization
Companies near LungLife AI Inc in the global market cap rankings as of September 23, 2026. Review how tangible is LungLife AI Inc's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to LungLife AI Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #89 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #155 globally with a market cap of $156.17 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #456 globally with a market cap of $60.75 Billion USD ( CN¥415.14 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #581 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #89 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $658.52 |
| #155 | Danaher Corporation | NYSE:DHR | $156.17 Billion | $221.09 |
| #456 | WuXi AppTec Co Ltd | SHG:603259 | $60.75 Billion | CN¥167.85 |
| #581 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $390.90 |
LungLife AI Inc Historical Marketcap From 2021 to 2025
Between 2021 and today, LungLife AI Inc's market cap moved from $701.29K to $ 15.48K, with a yearly change of -63.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | GBX15.48K | -51.18% |
| 2024 | GBX31.71K | -81.52% |
| 2023 | GBX171.59K | -45.88% |
| 2022 | GBX317.07K | -54.79% |
| 2021 | GBX701.29K | -- |
End of Day Market Cap According to Different Sources
On May 27th, 2026 the market cap of LungLife AI Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.48K USD |
| MoneyControl | $15.48K USD |
| MarketWatch | $15.48K USD |
| marketcap.company | $15.48K USD |
| Reuters | $15.48K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About LungLife AI Inc
LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. The company engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, I… Read more